UNIVERSITY OF SOUTH FLORIDA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1956-01-01

Employees: 10K

Market Cap: -

Website: http://www.usf.edu

Clinical Trials

Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders

Phase 2

Completed

Conditions: Autism
Social Phobia
Obsessive-compulsive Disorder
Asperger's Syndrome
Separation Anxiety Disorder
Generalized Anxiety Disorder

Interventions: Behavioral: Cognitive-behavioral therapy
Behavioral: Treatment as Usual

First Posted Date: 2010-08-10

Last Posted Date: 2013-04-02

Lead Sponsor: University of South Florida

Target Recruit Count: 45

Registration Number: NCT01178385

Locations: 🇺🇸
Rothman Center for Neuropsychiatry, University of South Florida, St. Petersburg, Florida, United States

Randomized Clinical Trial: Expectant Management vs Laser Treatment of Monochorionic Twins With Severe Selective Intrauterine Growth Retardation and Absent or Reverse Diastolic Flow in the Umbilical Artery

Not Applicable

Completed

Conditions: Intrauterine Growth Retardation

Interventions: Device: Expected Management
Procedure: selective laser photocoagulation of communicating vessels

First Posted Date: 2010-08-09

Last Posted Date: 2013-02-21

Lead Sponsor: University of South Florida

Target Recruit Count: 5

Registration Number: NCT01177553

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
University of South Florida, Tampa, Florida, United States

Glutathione (GSH) In The Treatment of Parkinson's Disease

Phase 2

Completed

Conditions: Parkinson's Disease

First Posted Date: 2010-08-09

Last Posted Date: 2010-08-09

Lead Sponsor: University of South Florida

Target Recruit Count: 20

Registration Number: NCT01177319

Locations: 🇺🇸
USF Parkinson's Disease and Movement Disorders Center, Tampa, Florida, United States

Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents

Phase 1

Completed

Conditions: Anxiety Disorders in Youth With Autism, Asperger's Syndrome, and Pervasive Developmental Disorder Not Otherwise Specified

Interventions: Behavioral: Cognitive-Behavioral Therapy
Behavioral: Wait-list

First Posted Date: 2010-08-09

Last Posted Date: 2014-07-01

Lead Sponsor: University of South Florida

Target Recruit Count: 33

Registration Number: NCT01177969

Locations: 🇺🇸
Univeristy of California at Los Angeles, Los Angeles, California, United States
🇺🇸
University of South Florida, St. Petersburg, Florida, United States

Brain Fitness in Parkinson's Disease

Phase 3

Completed

Conditions: Parkinson's Disease

Interventions: Other: No contact-control group
Behavioral: InSight

First Posted Date: 2010-07-01

Last Posted Date: 2012-12-10

Lead Sponsor: University of South Florida

Target Recruit Count: 87

Registration Number: NCT01155349

Locations: 🇺🇸
University of South Florida, Tampa, Florida, United States

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Phase 3

Terminated

Conditions: Cancer

Interventions: Other: placebo
Drug: cyproheptadine hydrochloride

First Posted Date: 2010-05-28

Last Posted Date: 2015-07-02

Lead Sponsor: University of South Florida

Target Recruit Count: 22

Registration Number: NCT01132547

Locations: 🇺🇸
Connecticut Children's Medical Center, Hartford, Connecticut, United States
🇺🇸
Children's Hospital of Southwest Florida at Lee Memorial, Fort Myers, Florida, United States
🇺🇸
Miller Children's Hospital, Long Beach, California, United States

and more 11 locations

An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.

Phase 4

Completed

Conditions: Gout

Interventions: Other: Magnetic Resonance Imaging
Drug: Febuxostat
Drug: Colchicine

First Posted Date: 2010-04-29

Last Posted Date: 2019-08-07

Lead Sponsor: University of South Florida

Target Recruit Count: 74

Registration Number: NCT01112982

Locations: 🇺🇸
University of South Florida Medical Clinics, Tampa, Florida, United States

The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) Treatment

Completed

Conditions: Multiple Sclerosis

First Posted Date: 2010-02-11

Last Posted Date: 2012-06-18

Lead Sponsor: University of South Florida

Target Recruit Count: 20

Registration Number: NCT01067573

Locations: 🇺🇸
USF Health, Tampa, Florida, United States

Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease

Phase 4

Completed

Conditions: Overactive Bladder in Parkinson's Disease

Interventions: Drug: placebo
Drug: solifenacin succinate (VESIcare)

First Posted Date: 2009-11-23

Last Posted Date: 2021-11-09

Lead Sponsor: University of South Florida

Target Recruit Count: 23

Registration Number: NCT01018264

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
University of South Florida, Tampa, Florida, United States
🇺🇸
University of Miami, Miami, Florida, United States

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Phase 2

Completed

Conditions: Breast Cancer
Cardiac Toxicity

Interventions: Drug: lisinopril
Drug: Coreg CR®
Other: placebo

First Posted Date: 2009-11-09

Last Posted Date: 2021-03-30

Lead Sponsor: University of South Florida

Target Recruit Count: 468

Registration Number: NCT01009918

Locations: 🇺🇸
Illinois CancerCare - Havana, Havana, Illinois, United States
🇺🇸
Saint Luke's Hospital, Chesterfield, Missouri, United States
🇺🇸
Illinois CancerCare - Canton, Canton, Illinois, United States

and more 171 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy